Korean diagnostics biotech goes Trans-Pacific, agreeing to shell out $1.5B to take US diagnostics maker private

A Korean diagnostics player that made millions of Covid-19 tests in the early stages of the pandemic is now expanding into the US market.

Cincinnati-based Meridian Bioscience put up notice Thursday morning that it’s going to be acquired by SD Biosensor, accompanied by investment firm SJL Partners for $1.53 billion in cash.